The Role of Point-of-Care Testing in Diabetes Management
HbA1c testing is a cornerstone in diabetes management, offering a snapshot of a patient’s average blood sugar levels over the past 2-3 months. Traditionally, these tests are conducted in central laboratories, often requiring patients to wait for follow-up appointments to discuss results. However, with point-of-care testing like the spinit® HbA1c, results are available during the same consultation. This reduces delays, increases patient engagement, and allows for real-time adjustments to treatment plans. Studies show that immediate feedback can significantly improve glycaemic control, reducing the risk of complications such as cardiovascular disease, neuropathy, and kidney damage.
The Global Diabetes Burden
The urgency for effective diabetes management is underscored by alarming global statistics:
- Every 3 seconds, someone develops diabetes.
- More than 50% of Type 2 diabetes cases could be prevented or delayed through early diagnosis and lifestyle interventions.
- Diabetes is a leading cause of blindness, amputations, and kidney failure worldwide.
Together, we can make a significant impact in the fight against diabetes.
_______________________________________________________________
References:
1. International Diabetes Federation (IDF). IDF Diabetes Atlas, 10th Edition. 2023.
2. World Health Organization (WHO). Diabetes Fact Sheet. 2023.
3. Diabetes UK. The Importance of HbA1c in Diabetes Care. 2024.